In the News
February 2021: We are pleased to announce that the manuscript - BBCIC Research Network Analysis of First-Cycle Prophylactic G-CSF Use in Patients Treated with High Neutropenia Risk Chemotherapy – has been accepted for publication in the Journal of the National Comprehensive Cancer Network.
January 2021: We are pleased to announce that the manuscript - Patient Characteristics and Utilization Patterns of Short-Acting Recombinant Granulocyte Colony-Stimulating Factor (G-CSF) Biosimilars Compared to Their Reference Product - has been published in the journal Drugs – Real World Outcomes.
Two BBCIC abstracts have been accepted for poster presentation at AMCP 2021:
Utilization patterns and characteristics of patients treated with the originator and follow-on insulin glargine in the United States. Presenting author Young Hee Nam, PhD, Harvard Pilgrim Healthcare Institute post-doctoral fellow.
Characterization of real-world data sources to support observational studies of biologics, including biosimilars in oncology. [Bronze medal winner]. Presenting author Ryan M. Seals, ScD, epidemiologist at Optum Life Sciences.
November 2020: We are pleased to announce that the manuscript - Utilization Patterns and Characteristics of Users of Biologic Anti-Inflammatory Agents in a Large, US Commercially Insured Population has been accepted for publication in the journal Pharmacology Research and Perspectives.
9/28/20: On Monday, Sept. 28, #BBCIC Executive Director Cate Lockhart moderated a session during @ispororg’s webinar on Biosimilars: Unleashing The Potential for Improved Patient Access and Cost Savings in the United States. View the recording. (Profile required)
September 2020: On September 16 & 17, 2020, Executive Director of BBCIC Cate Lockhart presented a poster on variations in evaluations of granulocyte colony stimulating factor use at the ICPE All Access virtual meeting. Learn more.
July 2020: Cate Lockhart Honored as UW School of Pharmacy "Alumni Legend"
We are delighted to announce that Cate Lockhart PhD, Executive Director of BBCIC has been selected as one of the 125 “Alumni Legends" as part of the 125th anniversary of the University of Washington School of Pharmacy.
2/29/16: Sentinel For Biosimilars? Biologics Post-Market Monitoring Is Focus Of New Consortium (Pink Sheet)
10/3/2022: FDA Awards $1.3 Million Grant to Biologics & Biosimilars Collective Intelligence Consortium
1/25/17: BBCIC Announces New Consortium Members Apobiologix and Sandoz
10/27/15: AMCP's BBCIC Achieves Major Milestone